Robert G. Spignesi Jr. Files Schedule 13D for Rapid Micro Biosystems, Inc.

Robert G. Spignesi Jr., President and CEO of Rapid Micro Biosystems, Inc., has filed a Schedule 13D disclosing beneficial ownership of approximately 6.3% of the company's Class A Common Stock. The filing details that Spignesi directly holds 493,931 shares and has the right to acquire additional shares through warrants and stock options. The shares were acquired using personal funds. Spignesi may acquire or dispose of additional shares in the future based on various factors, including the company's business prospects and market conditions. The filing also notes that Spignesi has not been convicted of any criminal proceedings or subject to any civil judgments related to securities laws in the past five years.